Disallowed Treatment Modalities

Updated
Policy Name:   Disallowed Treatment Modalities Policy
Effective Date: 01/01/2026
Review/Approval Date: 12/17/2025
Revision Date: 03/17/2026; 08/20/2026; 08/31/2026
Approved By:  Medical Director

Purpose:  

To facilitate the delivery of safe, evidence-based behavioral health care through Headway's platform, ensure patient safety and clinical integrity, and maintain compliance with payer and regulatory requirements by defining permitted and prohibited treatment modalities.

Applicability:  

Therapymatch, Inc., d/b/a as Headway, and its affiliates and subsidiaries (collectively, "Headway," "we," "us," or "our") and all of its associated Professional Corporations (PCs), including but not limited to all current and future PCs.

Definitions:

  • Behavioral Health Treatment — Interventions intended to diagnose, treat, or manage mental health or substance use conditions as defined by the DSM-5 or equivalent clinical standards.
  • Evidence-Based — Supported by credible scientific research demonstrating safety and efficacy and recognized by professional associations, licensing bodies, and/or payers.
  • Non-Behavioral Health Interventions — Services primarily intended to treat physical health conditions, cosmetic or aesthetic concerns, or other non-behavioral health needs.
  • Adjunctive Intervention — A supportive or complementary practice used in conjunction with, and subordinate to, an evidence-based behavioral health treatment modality.

Policy:

Headway permits only treatment modalities and interventions that are evidence-based, clinically appropriate for behavioral health care, and, when services are billed through a payer, eligible for reimbursement. Providers may not deliver, promote, advertise, document, or bill for interventions that fall outside recognized standards of behavioral health practice, including alternative, spiritual, energy-based, pseudoscientific, or non-clinical practices lacking credible scientific support.

Headway does not permit the provision or promotion of substance-assisted psychotherapy on its platform, including psychotherapy in which psychoactive substances are intentionally administered or present during treatment sessions. This list is non-exhaustive and may be updated as new substances or modalities emerge.

Procedures:

  1. General Expectations for Providers
    1. Deliver only treatment modalities supported by credible evidence of safety and efficacy within accepted behavioral health scope.
    2. Do not offer, promote, advertise, document, or bill for unsupported, non-evidence-based, or non-reimbursable modalities on the Headway platform.
    3. Ensure all billed services are eligible for reimbursement under applicable payer guidelines.
    4. Do not conduct, advertise, or document interventions primarily intended for physical health, cosmetic, or aesthetic purposes.
    5. When a patient may benefit from non-behavioral health or prohibited services, refer the patient to an appropriate outside provider.
  2. Prohibited Treatment Modalities
    1. Conversion-adjacent or coercive practices: Conversion therapy or any practice aimed at changing sexual orientation or gender identity; coercive or shame-based behavioral interventions related to identity; purging behaviors or facilitation of eating-disorder compensatory behaviors.
    2. Discredited or non-evidence-based psychotherapeutic practices: Primal therapy; Past Lives Regression therapy; Rebirthing therapy; Recovered memory-based therapy; Hypnoanalysis; Neuro-Linguistic Programming; Attachment holding therapy.
    3. Substance-assisted or psychoactive-facilitated psychotherapy: Including cannabis, psilocybin, MDMA, ketamine, esketamine (Spravato), oxytocin for psychotherapeutic purposes, and other psychedelic agents used during a psychotherapy session.
    4. Energy, spiritual, or pseudoscientific healing practices: Aura healing; chakra healing; crystal healing; gemstone therapy; vibrational essences; flower essences; Reiki; therapeutic touch; polarity therapy.
    5. Discredited or dangerous medical interventions: Antineoplastons; Coley's toxin; Laetrile; hydrazine sulfate; hydrogen peroxide therapy; ozone therapy; ultraviolet blood irradiation; Revici's guided chemotherapy; 714-X.
    6. Sexualized or erotic practices framed as therapy: Yoni practices; lingam practices.
    7. Aesthetic interventions: Weight-loss pharmacotherapy or procedures (except when clinically indicated to address weight gain caused by a behavioral health condition or its treatment); cosmetic procedures including Botox, fillers, or laser treatments.
    8. Out-of-scope treatments: Hormonal treatments for minors (< 18) including testosterone, androgen-blockers, estrogens, progesterone, or GnRH analogues.
    9. Illegal treatments: Any treatment prohibited under applicable laws in the state or locality where the provider is practicing.
  3. Restricted / Non-Standalone Interventions
    1. The following may not be offered, documented, promoted, or billed as standalone or primary services. They may be used only as adjunctive supports when an evidence-based behavioral health treatment is clearly documented as the primary modality:
      1. Expressive or experiential therapies: Dance/movement therapy; music therapy; psychodrama; therapeutic eurythmy.
      2. Mind-body or somatic adjuncts: Guided imagery; humor therapy; hypnosis; Trager approach; Feldenkrais method; Alexander technique; autogenic training.
      3. Complementary practices with limited mental health evidence: Aromatherapy; acupressure; reflexology; craniosacral therapy; Gua Sha; cupping; Tui Na; moxibustion.
      4. Movement-based wellness practices: Pilates; yoga; qigong.
      5. Technology-adjacent interventions: Vibro-acoustic therapy; whole body vibration; weighted blankets for panic/anxiety.
      6. Non-behavioral health medical interventions: IV vitamin/nutrient/hydration therapy; hormone replacement therapy.
  4. Accountability and Oversight
    1. Providers found to be in violation of this Policy may be subject to corrective action, including education, monitoring, suspension, or termination of the provider's contractual relationship with Headway.

References:

Disclaimer: This document is for educational purposes only and is not intended as professional or legal advice. It may contain errors or missing information, and recent changes in policies, regulations, or payer requirements may not be reflected. Because requirements vary by organization and jurisdiction, please consult legal counsel, the appropriate regulatory or licensing authority or your designated Headway contact for guidance specific to your situation.

Articles in this section